Target Profile
```
Patient's age must be greater than or equal to 18 years.
Patient must have active diagnosis of Breast cancer.
Patient must have active diagnosis of Metastasis from malignant tumor of breast.
Patient must not have active diagnosis of HER2-positive carcinoma of breast.
Patient must not have active diagnosis of Estrogen receptor positive tumor.
Patient must not have active diagnosis of Progesterone receptor positive tumor.
Patient must have historical medication within drug class Anthracycline Topoisomerase Inhibitor OR with ingredient docetaxel OR with ingredient Paclitaxel OR with ingredient ixabepilone.
Patient must have a health evaluation score of ECOG performance status grade:Prid:Pt:^Patient:Nom:Observed less than or equal to 1.
Patient must not have adverse event of Grade 2 Peripheral sensory neuropathy.
Patient must not have adverse event of Grade 3 Peripheral sensory neuropathy.
Patient must not have adverse event of Grade 4 Peripheral sensory neuropathy.
Patient must not have adverse event of Grade 5 Peripheral sensory neuropathy.
Patient must not have adverse event of Grade 2 Peripheral motor neuropathy.
Patient must not have adverse event of Grade 3 Peripheral motor neuropathy.
Patient must not have adverse event of Grade 4 Peripheral motor neuropathy.
Patient must not have adverse event of Grade 5 Peripheral motor neuropathy.
```